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Abstract To assess the effect of lead exposure from cigarette
smoke on fetal growth, blood lead concentrations were mea-
sured using inductively coupled plasma mass spectrometry in
150 healthy pregnant women. Mean lead concentrations in
plasma and whole blood were significantly higher in the
smoking group compared with the nonsmoking group in each
trimester of pregnancy (p<0.001). Logistic regression analysis
showed the highest impact of the number of cigarettes smoked
per day for serum lead concentration (β=0.238; p<0.05), while
in whole blood, it was duration of smoking before conception
(β=0.297; p<0.001). Birth weight of the smoking mothers'
infants was significantly lower (mean±SEM, 3,192±50.8 and
3,569±49.6 g, respectively; p<0.001) and negatively correlat-
ed with lead levels in plasma (r=−0.38; p<0.001) and in whole
blood (r=−0.27; p<0.001). Therefore, it is suggested that
smoking during pregnancy increases lead concentrations in
maternal blood. Fetal exposure to low doses of lead in utero
may be a serious risk factor causing lower birth weight.
Keywords Blood lead . Pregnant women . Tobacco
smoking . Birth weight
Introduction
Cigarette smoking may be one of the most common sources of
lead (Pb) exposure affecting the general population. Tobacco
contains lead, which enters mainstream smoke and is inhaled
by smokers [1]. It has been estimated that between 1 and 5 μg
of lead could be inhaled from smoking 20 cigarettes per day
[2]. According to the World Health Organization (WHO),
tobacco smoke from burning one cigarette could contain from
17 to 980 ng Pb [3]. Despite the fact that in the last years a
decrease in the number of active smokers has been observed,
cigarette smoking still plays a significant role among hazard-
ous health-related behaviors. This is particularly disturbing for
pregnant women. Epidemiology studies conducted at the In-
stitute of Mother and Child indicated that in Poland between
25 and 30 % of pregnant women were active smokers and
close to 60 % were passive smokers (home and/or occupa-
tional exposure) [4].
At present, acute lead poisoning has become rare but
chronic low-level exposure to lead remains a public health
issue. Chronic low-level exposure may result in lead accumu-
lation in renal tubule, lung, hepatocyte, and calcified tissues. It
is well-known that lead accumulates mostly in the bones of the
body [5–8]. The body burden of lead stored in maternal bone
can be released during pregnancy and contribute to fetal lead
exposure since there is no protective barrier to the transpla-
cental transport of lead [9–11]. Because the body burden of
lead in smoking mothers is higher than in nonsmoking ones,
lead in maternal bones may therefore be mobilized during
pregnancy even if the mother has stopped cigarette consump-
tion [5, 11–13]. Elevated blood lead levels of pregnant women
can be a risk factor for gestational hypertension/preeclampsia,
spontaneous abortion, preterm labor, and premature rupture of
the fetal membrane (PROM) [14–17]. In addition, low-dose
lead exposure in utero may have an adverse effect on birth
weight and developmental delays in children [18, 19]. A
variety of studies have shown that chronic low-dose lead can
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be associatedwith higher concentrations of this heavy metal in
the blood of mothers and infants, but information on the effect
of smoking on lead storage through pregnancy is limited
[20–23].
Therefore, the main objective of this study was to evaluate
the effect of cigarette smoking on plasma and whole blood
lead levels in pregnant women. The correlations between
concentrations of lead and markers of estimated intensity of
cigarette smoking (serum cotinine level, number of cigarettes/
day, duration of smoking before conception) were studied.




This was a case–control association study, which examined
the lead status of tobacco smoking pregnant women engaged
in regular clinic visits in the Department of Obstetrics and
Gynecology Institute of Mother and Child and the Warsaw
Medical University, Warsaw, Poland. All pregnant volunteers
were made aware of the objectives of the study and signed a
written informed consent form. The study was carried out
according to the principles of the Declaration of Helsinki
and was approved by the Ethical Committee of the Institute
of Mother and Child.
One hundred and fifty healthy pregnant women were
recruited for the study. Inclusion criteria were uncomplicated
singleton pregnancies and the first trimester of pregnancy.
Gestational age was estimated by the last menstrual period
and confirmed by ultrasonographic measurements of the
crown-rump length. Exclusion criteria were preeclampsia,
hypertension, diabetes mellitus, active hepatitis, renal and
cardiovascular diseases, and inflammatory conditions. The
socioeconomic status of all subjects was similar. All of them
were living in an urban area; none of the mothers drank
alcohol; none of the fetuses showed abnormalities.
At the first control visit, a history of smoking was obtained
by direct questioning of the pregnant women. Smokers
were defined as those women who reported their smoking
habit as maintained at a rate of minimum five cigarettes per
day and minimum 2 years before conception and continued
smoking during pregnancy. Nonsmokers were defined as
those women who had never smoked and were not exposed
to environmental tobacco smoke during their pregnancy
(smoking spouse or co-workers). The classification was con-
firmed by measurement of serum cotinine concentration in
pregnant women—the major metabolite of nicotine. The con-
centration of serum cotinine at a level of 15μg/Lwas accepted
as the limit value between the nonsmoking and smoking
group.
Collection and Analysis of Blood Samples
Fasting blood was obtained from women by venipuncture in
the first, second, and third trimester of pregnancy. Blood was
collected in the usual manner, but the full blood count sample
was collected into verified trace metal free EDTA tubes (BD,
UK). In order to obtain plasma, the blood was centrifuge at
2,500×g, at 4 °C for 10 min. Whole blood samples as well as
plasma and serum were frozen until measurements of lead
and cotinine concentrations were performed (−20 °C, max.
2 months).
An Inductively Coupled Plasma Mass Spectrometer (Elan
6100, Perkin Elmer, Canada) equipped with a Mainhard spray
chamber, quartz Scott's chamber, and platinum cones was
used. The experimental conditions were optimized according
to standard procedure by setting the flow of nebulizer gas
(argon), position of the nebulizer, positions of the cones, and
focusing lenses. Under optimized conditions, it was possible
to obtain adequate sensitivity and to reduce interference from
doubly charged ions and oxides. Three isotopes of lead
(206Pb, 207Pb, 208Pb) were monitored during the measure-
ments. The instrumental parameters were as follows: nebuliz-
er gas flow, 0.81 L/min; auxiliary gas flow, 1.20 L/min; plasma
gas flow, 14.50 L/min; lens voltage, 7.8 V; and ICP RF Power,
1,100 W.
Blood samples were diluted 10×, and plasma samples were
diluted 5× with Mili-Q (Milipore, USA) high purity water
before measurements. In order to prevent clogging of the
nebulizer tubes, all aliquots were filtered using syringe
polyamide-nylon filters with a pore size of 0.45 μm. Pb
concentration was determined using an external calibration
curve. The calibration standards were prepared by appropriate
dilution of the multi-elemental ICP-MS stock standard solu-
tion (Merck, Germany). Accuracy of the determinations was
verified by analyzing the reference material (Seronorm blood
serum) with certified lead content. The obtained results were
in accordance with the certificate.
Cotinine levels in serum were determined by immunoenzymatic
method using a commercially available kit (Cotinine one-
step ELISA, Calbiotech Inc., USA).
Statistical Analysis
Statistical analysis was done using STATISTICA 8.0
(StatSoft, Poland) software. The results are presented as
means±standard error of the mean (SEM) for normally dis-
tributed data or medians and interquartile range (25th–75th
percentiles) for non-normally distributed variables. Shapiro–
Wilk's test was used for evaluation normality of data distribu-
tion prior to statistical analysis. Student's t test was used for
comparison of normally distributed data and nonparametric
Wilcoxon's test for non-normally distributed variables. Pear-
son and Spearman correlation coefficients were calculated for
170 Chelchowska et al.
the determination of the association between the studied
markers. Univariate and multivariate linear regression models
with natural logarithm-transformed concentration of lead as a
dependent variable were estimated to examine the potential
impact of number of the cigarettes/day, duration of smoking
before conception, and cotinine level. In the univariate model,
we analyzed each factor separately whereas in the multivariate
one, they were all analyzed simultaneously. Results were
expressed as the value of β standardized regression coefficient
and its significance. The differences were regarded as statisti-
cally significant at p<0.05.
Results
The clinical characteristics of the pregnant women are shown
in Table 1. A total of 150 patients were included in the study,
70 smoking and 80 nonsmoking women in similar weeks of
gestation. Maternal characteristics were comparable in the
studied groups except for cigarette smoking habits. The mean
number of cigarettes per day for smokers was 8.8, and the
mean duration of smoking before conception was 8.4 years. In
the group of smoking mothers, serum cotinine concentration
amounted 76.1 μg/L and correlated positively with the daily
number of cigarettes consumed (r=0.70; p=0.009). In the
tobacco abstinent group, serum cotinine was present only in
two women in trace amounts (1.2 and 5.9 μg/L). Newborn
gestational age was similar in the two studied groups, and
there were no negative pregnancy outcomes or complications
during delivery in the nonsmoking as well as smoking wom-
en. The birth weight of the smoking mothers' infants was
significantly lower (p<0.001), but length, head circumfer-
ence, and Apgar score was similar in the two groups.
There was a negative correlation between birth weight and
lead level in maternal plasma (r=−0.38; p<0.001) as well as
in whole blood (r=−0.27; p<0.001) in the group of smoking
women. Additionally, lead concentrations in the mothers'
plasma correlated negatively with birth length (r=−0.28;
p<0.001) and head circumference (r=−0.27; p=0.006). Both
plasma and whole blood median concentrations of lead were
significantly higher in the smoking group compared with the
nonsmoking one (Tables 2 and 3). Similar results were ob-
served in the case of the mean values (plasma: I trimester, 0.28
vs 0.09 μg/dL; II trimester, 0.24 vs 0.07 μg/dL; III trimester,
0.39 vs 0.06 μg/dL; whole blood: I trimester, 2.2 vs 1.5 μg/
dL; II trimester, 2.2 vs 1.3 μg/dL; III trimester, 2.6 vs 1.6 μg/
dL; p<0.001). In the group of smokers, plasma Pb concentra-
tion correlated positively with whole blood levels of this
element (r=0.34, p<0.001).
In Table 4, we presented the results of univariate and
multivariate model of linear regression. In the univariate mod-
el, all three factors were significant predictors of the level of
lead both in the serum and in whole blood. The highest impact
of the number of cigarettes smoked per day was indicated for
the serum lead concentration while in whole blood, it was
duration of smoking before conception. In multivariate





Age (year) 29.5 (26.9–32.2)b 30.1 (28.4–33.8)b
Gestational age (week)
I Trimester 12 (12–13)b 12 (12–13)b
II Trimester 21 (20–24)b 20.5 (20–22)b
III Trimester 31 (30–33)b 31 (30–32,5)b
Gestational age of birth (week) 38 (39–40)b 38.5 (39–40)b
Number of cigarettes/day 8.8±0.47a 0
Duration of smoking before
conception (year)
8.4±0.50a 0
Serum cotinine (μg/L) 76.1±4.22a 0
Birth weight (g)
Whole group 3,192±50.8a, * 3,569±49.6a
Girls 3,239±50.3a, * 3,509±49.4a
Boys 3,147±49.5a, * 3,603±49.9a
Birth body length (cm)




Whole group 34.7±0.24a 35.0±0.12a
Girls 33.8±0.22a 34.6±0.10a
Boys 35.6±0.23a 35.4±0.12a
Apgar score (5th min)
Whole group (100 %) 10 (10–10)b 10 (10–10)b
Girls (40 %) 10 (10–10)b 10 (10–10)b
Boys (60 %) 10 (10–10)b 10 (10–10)b
*p<0.001
aValues are means±standard error of the mean (SEM);
b Values are median and interquartile range (25th –75th percentiles)
Table 2 Lead concentration in plasma in smoking and nonsmoking
women in the course of pregnancy
Lead concentration (μg/dL)







I Trimester 0.22 0.14–0.40 0.05 0.02–0.11 <0.001
II Trimester 0.21 0.14–0.30 0.04 0.02–0.08 <0.001
III Trimester 0.25 0.17–0.34 0.06 0.02–0.10 <0.001
Entire pregnancy 0.23 0.15–0.35 0.05 0.02–0.10 <0.001
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analysis, cotinine concentration did not qualify for final
models probably because it has a strong correlation with other
factors (for the number of cigarettes/day, r=0.723). The mul-
tivariate analysis model estimated for serum lead levels
showed only a significant association with the number of
cigarettes/day (p=0.014). However, when cotinine level was
excluded, the remaining two factors appeared to be signifi-
cant, with p<0.001 and p=0.001, for the number of cigarettes/
day and duration of smoking before conception, respectively
(data not shown).
A similar multivariate model estimated for lead in whole
blood showed only a significant impact of duration of
smoking before conception (p<0.001). The result obtained
for the number of cigarettes/day was close to significance
level (p=0.054). In the model without cotinine, the number
of cigarettes/day and duration of smoking before conception
were significant at a level of p=0.001 and p<0.001, respec-
tively (data not shown).
Discussion
Chronic exposure to low doses of lead is increasingly exam-
ined in the context of reproductive health. In order to assess
personal exposure of pregnant women and their children to
lead, the Center for Disease Control (CDC) in Atlanta, USA,
developed criteria for interpreting test results, which are now
widely used in Poland. Blood lead levels of 10 μg/dL are
considered borderline and safe for pregnant women and their
children [20, 24]. However, a lead concentration below 5 μg/
dL is now regarded to be safe for pregnant women as a result
of numerous observations of the negative effects of low doses
of lead levels [14, 15, 25]. According to the World Health
Organization, blood lead levels of 10–15 μg/dL can cause
adverse reproductive outcomes [3].
Research on lead concentration in the blood of pregnant
women has been conducted for many years, but the results
have been inconclusive. The average concentrations of lead in
blood of pregnant women reported by other authors have been
presented in Table 5. Our results obtained in the full group of
pregnant women without taking into account the duration of
addiction to smoking and gestational age were similar to those
observed in the population of the US, Brazil, and Sweden and
belong to the lowest among the cited research. An important
contributory factor to the differences in concentrations of lead
among these studies is the differential bioavailability of trace
elements due to nutrient–nutrient interaction [18]. Recent
research documented that metal bioavailability (particularly
in edible plant products) was affected by the metal species,
gastrointestinal acidity, and the composition in the stomach
and intestine, including inorganic and organic components
and digestive enzymes [35, 36]. The relatively low level of
lead in the studied group may be due to the fact that all of our
patients confirmed consumption of multivitamins containing
calcium and iron, and in the course of prevention of neural
tube defects were supplemented with folic acid, which can
reduce the absorption of lead in the intestinal tract [37].
Similarly to others authors, we observed a decline in blood
lead levels between 12 and 20 weeks of gestation, which can
be explained by severe fetal organogenesis and decreased
concentrations of red blood cells due to the increase in plasma
volume during pregnancy. After 20 weeks, blood lead levels
rose, peaking in the third trimester [32, 38–40].
Cigarette smoking has been identified as a significant pre-
dictor of increased blood lead levels in the general adult
population [37, 41–44]. There are several published studies
that analyze the association between maternal smoking and its
Table 3 Lead concentration in whole blood in smoking and nonsmoking
women in the course of pregnancy
Lead concentration (μg/dL)







I Trimester 1.99 1.23–3.22 1.33 0.84–1.85 <0.001
II Trimester 2.01 1.25–2.46 1.30 0.81–1.69 <0.001
III Trimester 2.01 1.56–3.45 1.35 0.93–2.25 <0.001
Entire pregnancy 2.00 1.36–2.99 1.33 0.85–1.90 <0.001
Table 4 Linear regression analysis examining the relation of log blood lead levels and covariates both in univariate and multivariate models
Independent variable Plasma lead concentration Whole blood concentration
Univariate model Multivariate model Univariate model Multivariate model
β p value β p value β p value β p value
Number of cigarettes/day 0.337 <0.001 0.238 0.014 0.359 <0.001 0.177 0.054
Duration of smoking before conception (year) 0.269 <0.001 0.142 0.061 0.409 <0.001 0.297 <0.001
Cotinine level 0.291 <0.001 0.051 0.600 0.344 <0.001 0.075 0.424
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effect on blood lead levels during pregnancy Moreover, the
results of these studies were controversial since significant
differences were found in some of them [17], while no differ-
ences were observed in others [34, 45]. In the presented study,
similarly to our previous results, concentrations of blood lead
among smokers were significantly higher compared with to-
bacco abstainers in each trimester of pregnancy [46]. In agree-
ment with Miranda et al. [23], the frequency of lead levels
above 2 μg/dL (amounts considered to require observation)
was 15–20 % higher in the studied smoking group compared
with the nonsmokers. Rhainds and Levallois [2] found a
correlation between the daily number of cigarettes smoked
by the mother and the concentration of lead in cord blood. The
results of the presented study, both in univariate and multivar-
iate analysis, demonstrated a positive relationship of these
indicators both in whole blood and in plasma, which confirms
the negative impact of smoking on the blood levels of this
element. Another important issue is that mothers who stopped
smoking during pregnancy had higher concentrations than
nonsmoking mothers, which may be a reflection of the release
of lead from bones [5, 12, 13]. We have demonstrated the
relationship between blood lead concentration and duration of
cigarette smoking before conception, which seems to confirm
these observations.
Lead concentration both in whole blood and plasma has
been used for a more complete characterization of assessment
of lead status in pregnant women.Whole blood level has been
a generally acceptable biomarker to diagnose lead exposure,
but this measurement reflects recent exposure, while the plas-
ma Pb level is probably more relevant to assess health risk [5,
47–49]. Recent studies pointed to the toxic effects of lead,
mainly associated with the most rapidly exchangeable fraction
(the plasma fraction) which is associated with the harmful
effects of Pb [50, 51]. Although 99 % of lead in whole blood
is bound to red blood cells, only lead that is available to cross
the placenta is derived from lead that is in the free-state in
plasma [5, 26, 51]. Chuang et al. [5] showed that exposure to
lead in the air, including cigarette smoke, significantly affects
its level in the plasma, without affecting its concentration in
whole blood. In addition, the authors presented a model which
demonstrated a significant contribution of lead from the skel-
etal system to plasma during pregnancy, a contribution that is
independent of the influence of maternal RBC lead [5]. In our
study, tobacco smoking influenced lead status both in plasma
and in whole blood. However, we found that in plasma at the
end of pregnancy when the processes of mobilization of
calcium from the bones along with the release of lead was
most expressed, the concentration was at the highest value
while in whole blood, it did not differ significantly between
trimesters. Moreover, we observed the strongest negative
correlation between the level of these elements in plasma
and parameters of fetal growth. In agreement with Chuang
et al. [5], we suggested that plasma lead can be an important
biomarker for endogenous and exogenous lead exposure in
pregnant women and their fetus.
Maternal smoking during pregnancy and prenatal exposure
to chronic low doses were shown to be potentially associated
with reduced weight at birth, length, and head circumference
[20, 36, 52, 53]. To our knowledge, the present study is the
first to assess the association between concentrations of lead in
blood of mothers who smoke tobacco during each trimester of
pregnancy and birth anthropometric parameters. We found
that children of smoking mothers were about 300–400 g
smaller than newborns of the tobacco abstinent group. Among
all the participants, 5.4 % of newborns had a birth weight
below 2,500 g, which was accompanied by the mother's whole
blood lead level in excess >4 μg/dL. In our study, comparable
to the findings of The Port Pirie cohort study, prenatal lead
exposure and birth weight were in an inverse relationship with
maternal blood lead values [54]. Negative correlations be-
tween plasmamaternal lead concentration and newborn length
and head circumference seem to confirm the negative effect of
this element on fetal growth. An association with occupational
lead exposure and birth weight of under 2,500 g was found,
but the authors did not directly measure lead levels or control
smoking status, which is a common confounding variable
[21]. Some clinical data demonstrated that prenatal lead ex-
posure may not affect growth as an isolated factor; the cumu-
lative effects of prenatal and postnatal lead exposure may
Table 5 Reported value for concentration of lead (μg/dL) in whole blood
of pregnant women
Country N Lead (μg/dL) References
Mexico 272 8.90±4.10a Gonzales-Cossio et al.
(1997)[26]
Sweden 88 1.14 (0.21–
4.76)b
Osman et al. (2000)[27]
Canada 160 2.10±1.70a Smargiassi et al.
(2002)[28]
USA 140 1.96±0.84a Harville et al. (2005)[12]
Turkey 143 2.80±1.50a Kirel et al. (2005)[29]
Russia 48 5.00±3.00a Eik Anda et al. (2007)[30]
Portugal 182 7.10±2.80a Reis et al. (2007)[31]
France 865 1.90±1.20a Yazbeck et al. (2009)[17]
Nigeria (Lagos) 214 59.50±2.10a Adekunle et al. (2009)[32]
Brazil 120 1.74±0.09a Amaral et al. (2010)[33]
Iran 296 3.69±1.85a Vigeh M et al. (2010)[14]
China 128 5.95±2.27a Jiang et al. (2011)[34]
Saudi Arabia 1,577 2.89±1.85a Al.-Saleh et al. (2011)[11]
Nigeria (Abakaliki) 349 36.37±18.45a Ugwuja et al. (2011)[18]
Poland 150 1.89±1.10a Present study (2013)
N number of studied participants
aMean ± standard deviation (SD)
bMedian and range
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affect extrauterine growth [51, 55]. Several investigators ob-
served the influence of blood lead levels on reduced weight at
birth in newborns of mothers who drank and smoked during
pregnancy. In this case, the effect of both alcohol and tobacco
smoking on size at birth could be related to lead toxicity [2,
54]. In our research, all the studied women declared absti-
nence from alcohol during pregnancy and they were not
exposed to an additional source of lead at work.
There is an increasing number of evidence that prenatal
exposure to low doses of lead can be a risk factor for many
health complications for both mother and child [13–16, 20,
22, 56]. Information on the risk of intrauterine exposure to low
doses of lead resulting from smoking during pregnancy may
be useful in the practice of gynecology and obstetrics. Our
data confirm that lead concentration below 5 μg/dL may be a
risk factor affecting lower birth weight, the latter being one of
the strongest predictors of neonatal survival, mental impair-
ment, and future health status. It is therefore extremely impor-
tant to provide educational activities and interventions
designed to reduce smoking in the population of pregnant
women.
In conclusion, we found that blood lead levels in all three
trimesters in the tobacco smoking pregnant women were
higher than in the nonsmoking group. The significant rela-
tionship between the elevated concentration of this element in
the blood and the intensity of cigarette smoking seems to
confirm that the increase is a direct result of the inhalation of
lead from the smoke. The results of our study also suggest that
in smokers, fetal exposure to low doses of lead in utero may be
a serious risk factor affecting lower birth weight compared
with the tobacco abstinent group.
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